110518 ⎘
ssDNA viruses; Details; Parvoviridae Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE
#2METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE
#3COMPOSITIONS USEFUL IN TREATMENT OF ORNITHINE TRANSCARBAMYLASE (OTC) DEFICIENCY
#4METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE
#5METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE
#6Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency
#7METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE
#8Murine parvovirus and uses thereof
#9Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency
#10METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE
#11Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency
#12Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency
#13Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency
#14Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy due to Friedreich ataxia
#15Methods and pharmaceutical compositions for the treatment of cardiomyopathy due to friedreich ataxia
#16Vaccines containing canine parvovirus genetic variants
#17Parvovirus cancer therapy and combination with chemotherapy
#18Vaccines containing canine parvovirus genetic variants
#19Vaccines containing canine parvovirus genetic variants